This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p><p></p><p>For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FRD865. CME/MOC/AAPA/IPCE credit will be available until February 8, 2027.</p><p></p><p>Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum</p><p></p><p> In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Blue Faery: The Adrienne Wilson Liver Cancer Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p><p></p><p><strong>Support<br /></strong>This activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, Eisai Inc., and Merck & Co., Inc., Rahway, NJ, USA.</p><p></p><p>Disclosure information is available at the beginning of the video presentation.

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

PVI, PeerView Institute for Medical Education

Prof. Dr. Peter R. Galle - Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum

FEB 12, 202692 MIN
PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Prof. Dr. Peter R. Galle - Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum

FEB 12, 202692 MIN

Description

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p><p></p><p>For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FRD865. CME/MOC/AAPA/IPCE credit will be available until February 8, 2027.</p><p></p><p>Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum</p><p></p><p> In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Blue Faery: The Adrienne Wilson Liver Cancer Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p><p></p><p><strong>Support<br /></strong>This activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, Eisai Inc., and Merck & Co., Inc., Rahway, NJ, USA.</p><p></p><p>Disclosure information is available at the beginning of the video presentation.